Trials / Sponsors / Immune Oncology Research Institute
Immune Oncology Research Institute
Academic / Other · 6 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Cardiac Angiosarcoma International Registry Cardiac Angiosarcoma | — | 2025-05-01 |
| Recruiting | Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non Non-small Cell Lung Cancer | Phase 2 | 2024-06-13 |
| Recruiting | Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMON Lymphoma | Phase 2 | 2023-09-01 |
| Unknown | Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone Pediatric Cancer | Phase 3 | 2023-06-27 |
| Recruiting | Rare Embryonal Tumors of the Central Nervous System: International Registry Embryonal Tumor | — | 2023-02-01 |
| Recruiting | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | — | 2022-07-01 |